1 / 20

Universities Allied for Essential Medicines

Universities Allied for Essential Medicines . Clara Matthiessen/Aaron Vogt. Universities Allied for Essential Medicines (UAEM). International, interdisciplinary student organisation Founded in 2001 at Yale University USA, Canada, Germany, UK, Norway, Denmark, soon Switzerland

terena
Download Presentation

Universities Allied for Essential Medicines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Universities Allied for Essential Medicines Clara Matthiessen/Aaron Vogt

  2. Universities Allied for Essential Medicines (UAEM) • International, interdisciplinary student organisation • Founded in 2001 at Yale University • USA, Canada, Germany, UK, Norway, Denmark, soon Switzerland • Access to Lifesaving Medicine

  3. Case studies

  4. Canada • Patient with high blood pressure • Treatment possibilities > 50 • Price 20 – 100 $ /yr • Easy Access / receive a prescription from your GP • Few Adverse Effects

  5. Southeast Asia Leishmaniasis (Kala Azar) • Treatment Possibilities: 5 • Price : $50-500/ 20-30 days • Adverse Effects: • Toxic • Gastrointestinale problems, fever, fatigue, change in BP, diabetes... • Access to the Treatment: rare

  6. Medical Patent Eflorithine - Produced in 1980. - The only effective treatment against trypanosomiasis (African Sleeping Sickness). - Sanofi Aventis had the patent for Eflorithine.

  7. 1995: No effect seen for cancer treatments with Eflorithine Sanofi Aventis - Stopped all production - Still had exclusive rights for Eflorithine for 5 more years

  8. 2000: Effect against unwished hairgrowth discovered Sanofi Aventis - started production of Vaniqa - Monopol for this Product New patent for 20 years more!

  9. The Problem

  10. The Access Gap Ten million people die needlessly each year because they do not have access to existing medicines and vaccines.

  11. The Research Gap 90% of research goes into only 10% of the global disease burden. There is no commercial interest in research on neglected diseases. [Drugs for Neglected Disease initiative www.dndi.org]

  12. UAEM History and Mission

  13. Our Mission Access promote access to medicines and medical innovations in low- and middle-income countries by changing norms and practices around academic patenting and licensing Innovation ensure that university medical research meets the needs of people worldwide Empowerment empower students to respond to the access and innovation crisis

  14. Our History In 2001, Yale medical and law students convinced the university and Bristol-Myers-Squibb to reduce the price of Stavudine by 95% in South Africa. 40 major research universities – including Harvard, Yale and Charité in Berlin – have committed to license globally-relevant biomedical research openly in low- and middle-income countries. This equitable licensing approach enables producers to manufacture affordable versions of new university-discovered medicines for neglected populations.

  15. UAEMs work

  16. The Role of Universities in Drug Development • Every single vaccine brought to market in the past 25 years has a contribution from university research. [Ashley Stevens, current President of AUTM; Access to Medicines panel discussion, Yale University March 25, 2008] • More than 1/3 of HIV drugs introduced between 2002 and 2006 involve a university patent.

  17. Our Work • Local and national campaigns at universities • University Administration /TTO • Political focus National, EU and WHO • Administration of chapters and working groups

  18. We are not alone ...

  19. ”The right to life includes the right to health and access to treatment” [Articles 1&25, Universal Declaration of Human Rights, United Nations General Assembly 1948.]

  20. A Chapter in Switzerland - www.essentialmedicine.org - lfendel@essentialmedicines.com - clara.matthiessen@gmail.com - andrea.mauracher@uzh.ch - Next German UAEM Meeting: 7th-9th of December in Münster - Next European UAEM Meeting: April 2013 in Copenhagen

More Related